Lantern Pharma Inc.

LTRN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.43

-$0.07 (-4.67%)

Sep 22, 2026, 12:35 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $19.14M

Enterprise Value $11.82M

Beta 2.30

Average Volume 214.65K

Shares Outstanding (Diluted) 12.42M

Shares Change YoY 15.19%

Institutional Ownership 18.63%

Exchange NASDAQ

ISIN US51654W1018

Price Performance

Price Change 1M -33.0%

Price Change 3M -60.8%

Price Change 6M -32.4%

Price Change YTD -51.8%

Price Change 1Y -63.9%

Price Change 3Y -58.9%

Price Change 5Y -87.7%

1M CAGR (ann.) -47.5%

1Y CAGR (ann.) -63.1%

5Y CAGR (ann.) -35.1%

All-Time CAGR -30.6%

Valuation

PE Ratio -0.93

Forward PE N/A

PEG Ratio -0.14

Forward PEG -0.04

PS Ratio N/A

Forward PS 1.30

PB Ratio -5.95

P/FCF Ratio -1.36

P/Adj. FCF Ratio -1.28

P/OCF Ratio -1.33

EV/Sales N/A

EV/EBIT -1.03

EV/EBITDA -1.03

EV/FCF -0.84

Earnings Yield -108.0%

FCF Yield -73.6%

Adj. FCF Yield -78.2%

Financial Health

Net Cash $7.32M

Total Debt $39.72K

Cash & Short-Term Investments $7.36M

Total Assets $8.6M

Current Ratio 1.96

Quick Ratio 1.96

Debt / Equity Ratio -0.01

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -354.47

Interest Coverage 0.00

Altman Z-Score -19.71

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.3%

Returns

Return on Assets -216.8%

Return on Equity -456.4%

Return on Invested Capital -358.0%

Return on Capital Employed -361.4%

Return on Tangible Assets -216.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 0.9%

EPS CAGR 5Y -4.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y 3.8%

FCF CAGR 5Y -4.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -11.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.35

EPS Growth Est (next Q) -10.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-14.08M

Free Cash Flow $-14.08M

Adj. Free Cash Flow $-14.97M

FCF Per Share -$1.13

OCF Per Share -$1.13

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-3.85K

Operating Income $-15.47M

EBITDA $-11.48M

Net Income $-18.65M

EPS (Diluted) -$1.62

Revenue / Employee N/A

Profit / Employee $-1.17M

Employees 16